IMB Imperial Brands Plc

TIDMIMB

RNS Number : 1756O

Imperial Brands PLC

06 October 2021

IMPERIAL BRANDS PLC

Legal Entity Identifier (LEI) No. 549300DFVPOB67JL3A42

6 October 2021

Pre-close trading update

   --      Delivering in line with guidance and on track to meet full year expectations 
   --      Focus on top five priority markets beginning to arrest long-term share declines 
   --      Market trials underway with heated tobacco in Czech Republic and Greece, and blu in the US 
   --      Significant new hires to strengthen capabilities across the Group 
   --      Continued strong cash generation supporting our planned investment behind the new strategy 

Chief Executive Stefan Bomhard commented "We have made good progress in implementing our strategy through a sharper management focus, greater investment behind our priority combustible tobacco markets and new market trials in heated tobacco and vapour. We are building a high-performance culture with the introduction of new more consumer-focused ways of working, and have made a significant number of new hires to enhance our capabilities in key areas. I am pleased to report the business continues to perform well and we remain on track to deliver our full-year results in line with expectations."

Group net revenue is expected to grow by around 1 per cent on an organic, constant currency basis, driven by continued strong pricing in tobacco.

In our combustibles business, greater focus on our five priority markets is beginning to stabilise the long-term aggregate market share performances in these markets with share expected to be slightly lower by around 2-3 basis points, compared with a 17 basis point decline in the prior year. We are stepping up our investment behind our strategic initiatives in each of these priority markets to drive performance improvements. Overall tobacco volumes are in line with expectations and total Group cigarette market share is expected to grow by c. 20 basis points. The net effect of the COVID-19 travel restrictions and changes in consumer buying patterns has been a small mix benefit, although this is beginning to reduce as restrictions are lifted and is likely to unwind further in FY22.

In Next Generation Products (NGP), we are committed through our new strategy to make a meaningful contribution to harm reduction, led by consumer needs. As anticipated, second-half NGP revenue is expected to be at a similar level to the first half, reflecting the impact of market exits as we focus on the categories and markets with the best potential for sustainable growth. We have taken steps this year to strengthen our capabilities and performance to create a solid foundation for future growth. In line with our strategy, we have launched market trials for our heated tobacco proposition in the Czech Republic and Greece, as well as a trial of an improved consumer marketing proposition for our vapour product, blu, in Charlotte, North Carolina. We will be monitoring the consumer response to these trials over the coming months and will update on progress during 2022.

Group adjusted organic operating profit growth is expected to be in line with our guidance of low to mid-single digit constant currency growth, reflecting significantly reduced losses in NGP and increased Distribution profit. The tobacco business has performed well although adjusted operating profit will be slightly lower than last year, as previously guided, as a result of the planned increased investment to support our strategic plan as well as lower stock revenue/profit in Australia (c. GBP90m) and US state litigation settlement costs (c. GBP50m).

At current exchange rates, translation foreign exchange is expected to be c. 3 per cent headwind to full year earnings per share. As previously announced, the adjusted effective tax rate is expected to increase this year from 21 per cent to around 23 per cent.

Full-year adjusted operating cash conversion is expected to be in line with expectations with the unwind of the temporary Logista cash benefits in FY20 resulting in a working capital outflow. We remain focused on strengthening the balance sheet and continue to make progress towards achieving our target leverage of the lower end of our 2-2.5 times net debt to EBITDA range on a sustainable basis.

The annual results for the 12 months ended 30 September 2021 will be announced on 16 November 2021.

ENDS

Notes:

The Group uses 'adjusted' (non-GAAP) measures as we believe they provide a better comparison between reporting periods. The definition of our adjusted measures is unchanged from our half-year results. We also use the term 'constant currency', which removes the effect of exchange rate movements on the translation of the results of our overseas operations. The term 'organic' excludes the impact of the Premium Cigar divestment, which completed on 29 October 2020. This excludes the contribution of the Premium Cigar business from both FY20 and FY21 results. The table below sets out the contribution of the Premium Cigar business to FY20 results:

 
                               FY20    Premium   FY20 organic 
                                        Cigars 
 Volume (bn SE)                239.1    (0.3)       238.8 
 Tobacco net revenue (GBPm)    7,784    (247)       7,537 
 Adjusted operating profit 
  (GBPm)                       3,527    (31)        3,496 
 Share of JV profits (GBPm)     45      (44)          1 
 Adjusted profit before 
  tax (GBPm)                   3,143    (75)        3,068 
 Adjusted earnings (GBPm)      2,403    (68)        2,335 
 Adjusted EPS (p)              254.4    (7.2)       247.2 
 
 
 Investor Contacts                    Media Contacts 
                    +44 (0)7970 328                     +44 ( 0)7740 096 
 Peter Durman        903              Jonathan Oliver    018 
                    +44 (0)7581 052                     +44 (0)7967 467 
 James King          880              Simon Evans        684 
                    +44 (0)7974 615 
 Jennifer Ramsey     739 
 

Cautionary Statement

Certain statements in this announcement constitute or may constitute forward-looking statements. Any statement in this announcement that is not a statement of historical fact including, without limitation, those regarding the Company's future expectations, operations, financial performance, financial condition and business is or may be a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected or implied in any forward-looking statement. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this announcement. As a result, you are cautioned not to place any reliance on such forward-looking statements. The forward-looking statements reflect knowledge and information available at the date of this announcement and the Company undertakes no obligation to update its view of such risks and uncertainties or to update the forward-looking statements contained herein. Nothing in this announcement should be construed as a profit forecast or profit estimate and no statement in this announcement should be interpreted to mean that the future earnings per share of the Company for current or future financial years will necessarily match or exceed the historical or published earnings per share of the Company. This announcement has been prepared for, and only for the members of the Company, as a body, and no other persons. The Company, its Directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this announcement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTGUBDGRBGDGBL

(END) Dow Jones Newswires

October 06, 2021 02:00 ET (06:00 GMT)

Imperial Brands (LSE:IMB)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Imperial Brands (LSE:IMB)
Historical Stock Chart
Von Apr 2023 bis Apr 2024